IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE

被引:263
作者
BERTILSSON, L
HENTHORN, TK
SANZ, E
TYBRING, G
SAWE, J
VILLEN, T
机构
关键词
D O I
10.1038/clpt.1989.40
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:348 / 355
页数:8
相关论文
共 41 条
[21]   EFFECTS OF AGE AND LIVER-DISEASE ON DISPOSITION AND ELIMINATION OF DIAZEPAM IN ADULT MAN [J].
KLOTZ, U ;
AVANT, GR ;
HOYUMPA, A ;
SCHENKER, S ;
WILKINSON, GR .
JOURNAL OF CLINICAL INVESTIGATION, 1975, 55 (02) :347-359
[22]   DIFFERENCES IN DIAZEPAM PHARMACOKINETICS IN CHINESE AND WHITE CAUCASIANS - RELATION TO BODY LIPID STORES [J].
KUMANA, CR ;
LAUDER, IJ ;
CHAN, M ;
KO, W ;
LIN, HJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (02) :211-215
[23]   PHARMACOGENETICS OF MEPHENYTOIN - A NEW DRUG HYDROXYLATION POLYMORPHISM IN MAN [J].
KUPFER, A ;
PREISIG, R .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :753-759
[24]   DETERMINATION OF DEBRISOQUINE AND ITS 4-HYDROXY METABOLITE IN BIOLOGICAL-FLUIDS BY GAS-CHROMATOGRAPHY WITH FLAME-IONIZATION AND NITROGEN-SELECTIVE DETECTION [J].
LENNARD, MS ;
SILAS, JH ;
SMITH, AJ ;
TUCKER, GT .
JOURNAL OF CHROMATOGRAPHY, 1977, 133 (01) :161-166
[25]   OXIDATION PHENOTYPE - A MAJOR DETERMINANT OF METOPROLOL METABOLISM AND RESPONSE [J].
LENNARD, MS ;
SILAS, JH ;
FREESTONE, S ;
RAMSAY, LE ;
TUCKER, GT ;
WOODS, HF .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (25) :1558-1560
[26]   POLYMORPHIC HYDROXYLATION OF DEBRISOQUINE IN MAN [J].
MAHGOUB, A ;
IDLE, JR ;
DRING, LG ;
LANCASTER, R ;
SMITH, RL .
LANCET, 1977, 2 (8038) :584-586
[27]   CLINICAL PHARMACOKINETICS OF DIAZEPAM [J].
MANDELLI, M ;
TOGNONI, G ;
GARATTINI, S .
CLINICAL PHARMACOKINETICS, 1978, 3 (01) :72-91
[28]   AMITRIPTYLINE METABOLISM - ASSOCIATION WITH DEBRISOQUIN HYDROXYLATION IN NONSMOKERS [J].
MELLSTROM, B ;
SAWE, J ;
BERTILSSON, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (04) :369-371
[29]   E-10-HYDROXYLATION AND Z-10-HYDROXYLATION OF NORTRIPTYLINE - RELATIONSHIP TO POLYMORPHIC DEBRISOQUINE HYDROXYLATION [J].
MELLSTROM, B ;
BERTILSSON, L ;
SAWE, J ;
SCHULZ, HU ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :189-193
[30]   INTERETHNIC DIFFERENCES IN GENETIC-POLYMORPHISM OF DEBRISOQUIN AND MEPHENYTOIN HYDROXYLATION BETWEEN JAPANESE AND CAUCASIAN POPULATIONS [J].
NAKAMURA, K ;
GOTO, F ;
RAY, WA ;
MCALLISTER, CB ;
JACQZ, E ;
WILKINSON, GR ;
BRANCH, RA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :402-408